Factors associated with type 2 diabetes mellitus in patients treated at an Amazon hospital in Peru
Keywords:
Diabetes Mellitus, Type 2, Metabolic Syndrome, Risk Groups.Abstract
Introduction: type 2 diabetes mellitus is a metabolic disorder of multiple etiologies characterized by chronic hyperglycemia and is associated with cardiovascular and renal complications.
Objective: to determine the sociodemographic and biological factors associated with type 2 diabetes mellitus in patients treated at the “II Essalud Pucallpa” hospital in the period 2018 - 2019.
Method: an observational, analytical and cross-sectional study was carried out. A sample of 124 patients was selected through simple random sampling. All data was collected from individual medical records and program books using the data collection form.
Results: a predominance of patients was found in the age group from 30 to 39 years of age (25,8 %), as well as the female sex (64,5 %). Body mass index greater than 25 had a statistically significant relationship with type 2 diabetes mellitus (p <0,05) and between the total cholesterol value, LDL above the optimum limit and HDL below 35mg/dl. 73,3 % of the patients with type 2 diabetes mellitus reported consuming more than one sugary drink per day, and 75% consumed alcohol, finding a statistically significant association (p <0.05). A predominance of metabolic syndrome patient’s (81,67 %) was found in in the group with type 2 diabetes mellitus.
Conclusions: the presence of type 2 diabetes mellitus was associated with the presence of high blood pressure, high body mass index, cholesterol, LDL and HDL; as well as the consumption of alcohol and sugary drinks.
Downloads
References
1. Jean-Marie E. Diagnosis and classification of diabetes mellitus. En: Encyclopedia of Endocrine Diseases. Elsevier; 2018. p. 105-9.
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993;16(2):434-44.
3. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med [Internet]. 2004 [citado 2020 Mar 12];15(7):539-53. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1002/%28SICI%291096-9136%28199807%2915%3A7%3C539%3A%3AAID-DIA668%3E3.0.CO%3B2-S
4. Seclén S. Diabetes Mellitus en el Perú: hacia dónde vamos. Rev Medica Hered [Internet]. 2015 [citado 2020 Mar 12];26(1):3. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1018-130X2015000100001
5. Dereje N, Earsido A, Temam L, Abebe A. Prevalence and Associated Factors of Diabetes Mellitus in Hosanna Town, Southern Ethiopia. Ann Glob Heal [Internet]. 2020 [citado 2020 Mar 20];86(1):18. Disponible en: https://annalsofglobalhealth.org/articles/10.5334/aogh.2663/
6. Huang ES, Basu A, O’Grady MJ, Capretta JC. Using Clinical Information To Project Federal Health Care Spending. Health Aff [Internet]. 1 2009 [citado 2020 Mar 12];28(Supplement 1):w978-90. Disponible en: http://www.healthaffairs.org/doi/10.1377/hlthaff.28.5.w978
7. Tuomilehto J, Schwarz P, Lindström J. Long-term benefits from lifestyle interventions for type 2 diabetes prevention: Time to expand the efforts. Diabetes Care [Internet]. 2011 [2020 Mar 12];34(s2):s210-214. Disponible en: https://care.diabetesjournals.org/content/34/Supplement_2/S210.short
8. Arredondo Bruce AE, Rodríguez Téllez S, Arredondo Rubido AE. Caracterización de los pacientes diabéticos tipo 2 con hipertensión arterial. Rev Méd Electrón [Internet]. 2019 [citado 2020 Mar 12];41(4). Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/3081/4306
9. Leiva AM, Martínez MA, Petermann F, Garrido-Méndez A, Poblete-Valderrama F, Díaz-Martínez X, et al. Factores asociados al desarrollo de diabetes mellitus tipo 2 en Chile. Nutr. Hosp. [Internet]. 2018 [citado 2020 Mar 12] ; 35( 2 ): 400-407. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112018000200400&lng=es.
10. de Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, et al. Diabetes and Hypertension: A Position Statement by the American Diabetes Association. Diabetes Care [Internet]. 2017 [citado 2020 Mar 12]; 40(9):1273-1284. Disponible en: http://care.diabetesjournals.org/content/40/9/1273.abstract
11. Petrie JR, Guzik TJ, Touyz RM. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol [Internet]. 2018 [citado 2020 Mar 12];34(5):575-84. Disponible en: http://www.sciencedirect.com/science/article/pii/S0828282X1731214X
12. Lee DH, Keum N, Hu FB, Orav EJ, Rimm EB, Willett WC, et al. Comparison of the association of predicted fat mass, body mass index, and other obesity indicators with type 2 diabetes risk: two large prospective studies in US men and women. Eur J Epidemiol [Internet]. 2018 [citado 2020 Mar 12];33(11):1113-23. Disponible en: https://doi.org/10.1007/s10654-018-0433-5
13. Hechavarría Naranjo S, Achiong Estupiñán F, Méndez Gómez H, Vega Rico O, Díaz Piñera A, Rodríguez Salvá A, Londoño Agudelo E. Caracterización clínica epidemiológica de la diabetes mellitus en dos áreas de salud. Municipio Cárdenas. 2017. Rev Méd Electrón [Internet]. 2019 [citado 2020 Mar 12];41(4). Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/3155/4378
14. Perego C, Da Dalt L, Pirillo A, Galli A, Catapano AL, Norata GD. Cholesterol metabolism, pancreatic β-cell function and diabetes. Biochimica et Biophysica Acta - Molecular Basis of Disease [Internet]. 2019 [citado 2020 Mar 12] ;1865(9):2149-56. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0925443919301231
15. Moosazadeh M, Asemi Z, Lankarani KB, Tabrizi R, Maharlouei N, Naghibzadeh-Tahami A, et al. Family history of diabetes and the risk of gestational diabetes mellitus in Iran: A systematic review and meta-analysis. Diabetes Metab Syndr Clin Res Rev [Internet]. 2017 [citado 2020 Mar 12]; 11:S99-104. https://www.sciencedirect.com/science/article/abs/pii/S1871402116302399
16. He HZ, Zhang T, Zhou J, Wang DP, Wang HJ, Song Y, et al. Relationship between sugary drinks and diabetes of adults in Wuhai city]. Beijing Da Xue Xue Bao [Internet]. 2018 [citado 2020 Mar 12];50(3):469-73. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/29930415
17. Drouin-Chartier J-P, Zheng Y, Li Y, Malik V, Pan A, Manson Je, et al. 152-OR: Changes in Consumption of Sugary Beverages and Artificially Sweetened Beverages and Risk of Type 2 Diabetes among U.S. Women and Men. Diabetes [Internet]. 2019 [citado 2020 Mar 12]; 42(12):2181-2189. Disponble en: https://care.diabetesjournals.org/content/42/12/2181.abstract
18. Llorente Columbié Y, Miguel-Soca PE, Rivas Vázquez D, Borrego Chi Y. Factores de riesgo asociados con la aparición de diabetes mellitus tipo 2 en personas adultas. Rev Cuba Endocrinol [Internet]. 2016 [citado 2020 Mar 12];27(2):123-33. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532016000200002
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993;16(2):434-44.
3. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med [Internet]. 2004 [citado 2020 Mar 12];15(7):539-53. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1002/%28SICI%291096-9136%28199807%2915%3A7%3C539%3A%3AAID-DIA668%3E3.0.CO%3B2-S
4. Seclén S. Diabetes Mellitus en el Perú: hacia dónde vamos. Rev Medica Hered [Internet]. 2015 [citado 2020 Mar 12];26(1):3. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1018-130X2015000100001
5. Dereje N, Earsido A, Temam L, Abebe A. Prevalence and Associated Factors of Diabetes Mellitus in Hosanna Town, Southern Ethiopia. Ann Glob Heal [Internet]. 2020 [citado 2020 Mar 20];86(1):18. Disponible en: https://annalsofglobalhealth.org/articles/10.5334/aogh.2663/
6. Huang ES, Basu A, O’Grady MJ, Capretta JC. Using Clinical Information To Project Federal Health Care Spending. Health Aff [Internet]. 1 2009 [citado 2020 Mar 12];28(Supplement 1):w978-90. Disponible en: http://www.healthaffairs.org/doi/10.1377/hlthaff.28.5.w978
7. Tuomilehto J, Schwarz P, Lindström J. Long-term benefits from lifestyle interventions for type 2 diabetes prevention: Time to expand the efforts. Diabetes Care [Internet]. 2011 [2020 Mar 12];34(s2):s210-214. Disponible en: https://care.diabetesjournals.org/content/34/Supplement_2/S210.short
8. Arredondo Bruce AE, Rodríguez Téllez S, Arredondo Rubido AE. Caracterización de los pacientes diabéticos tipo 2 con hipertensión arterial. Rev Méd Electrón [Internet]. 2019 [citado 2020 Mar 12];41(4). Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/3081/4306
9. Leiva AM, Martínez MA, Petermann F, Garrido-Méndez A, Poblete-Valderrama F, Díaz-Martínez X, et al. Factores asociados al desarrollo de diabetes mellitus tipo 2 en Chile. Nutr. Hosp. [Internet]. 2018 [citado 2020 Mar 12] ; 35( 2 ): 400-407. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112018000200400&lng=es.
10. de Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, et al. Diabetes and Hypertension: A Position Statement by the American Diabetes Association. Diabetes Care [Internet]. 2017 [citado 2020 Mar 12]; 40(9):1273-1284. Disponible en: http://care.diabetesjournals.org/content/40/9/1273.abstract
11. Petrie JR, Guzik TJ, Touyz RM. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol [Internet]. 2018 [citado 2020 Mar 12];34(5):575-84. Disponible en: http://www.sciencedirect.com/science/article/pii/S0828282X1731214X
12. Lee DH, Keum N, Hu FB, Orav EJ, Rimm EB, Willett WC, et al. Comparison of the association of predicted fat mass, body mass index, and other obesity indicators with type 2 diabetes risk: two large prospective studies in US men and women. Eur J Epidemiol [Internet]. 2018 [citado 2020 Mar 12];33(11):1113-23. Disponible en: https://doi.org/10.1007/s10654-018-0433-5
13. Hechavarría Naranjo S, Achiong Estupiñán F, Méndez Gómez H, Vega Rico O, Díaz Piñera A, Rodríguez Salvá A, Londoño Agudelo E. Caracterización clínica epidemiológica de la diabetes mellitus en dos áreas de salud. Municipio Cárdenas. 2017. Rev Méd Electrón [Internet]. 2019 [citado 2020 Mar 12];41(4). Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/3155/4378
14. Perego C, Da Dalt L, Pirillo A, Galli A, Catapano AL, Norata GD. Cholesterol metabolism, pancreatic β-cell function and diabetes. Biochimica et Biophysica Acta - Molecular Basis of Disease [Internet]. 2019 [citado 2020 Mar 12] ;1865(9):2149-56. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0925443919301231
15. Moosazadeh M, Asemi Z, Lankarani KB, Tabrizi R, Maharlouei N, Naghibzadeh-Tahami A, et al. Family history of diabetes and the risk of gestational diabetes mellitus in Iran: A systematic review and meta-analysis. Diabetes Metab Syndr Clin Res Rev [Internet]. 2017 [citado 2020 Mar 12]; 11:S99-104. https://www.sciencedirect.com/science/article/abs/pii/S1871402116302399
16. He HZ, Zhang T, Zhou J, Wang DP, Wang HJ, Song Y, et al. Relationship between sugary drinks and diabetes of adults in Wuhai city]. Beijing Da Xue Xue Bao [Internet]. 2018 [citado 2020 Mar 12];50(3):469-73. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/29930415
17. Drouin-Chartier J-P, Zheng Y, Li Y, Malik V, Pan A, Manson Je, et al. 152-OR: Changes in Consumption of Sugary Beverages and Artificially Sweetened Beverages and Risk of Type 2 Diabetes among U.S. Women and Men. Diabetes [Internet]. 2019 [citado 2020 Mar 12]; 42(12):2181-2189. Disponble en: https://care.diabetesjournals.org/content/42/12/2181.abstract
18. Llorente Columbié Y, Miguel-Soca PE, Rivas Vázquez D, Borrego Chi Y. Factores de riesgo asociados con la aparición de diabetes mellitus tipo 2 en personas adultas. Rev Cuba Endocrinol [Internet]. 2016 [citado 2020 Mar 12];27(2):123-33. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532016000200002
Downloads
Published
2020-05-01
How to Cite
1.
Rafael-Heredia A, Iglesias-Osores S. Factors associated with type 2 diabetes mellitus in patients treated at an Amazon hospital in Peru. Univ. Méd. Pinareña [Internet]. 2020 May 1 [cited 2025 Apr. 6];16(2):e493. Available from: https://revgaleno.sld.cu/index.php/ump/article/view/493
Issue
Section
Original Article
